---
created: 2025-04-13
updated: 2025-04-13T10:51
id: fxIW!gCyGA
specialty: neuro
specialty_id: 222
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - source/ak-step1-v11::
  - theme/b&b::03-biochem::03-amino-acids::02-phenylalanine-&-tyrosine
  - source/ak-step1-v11::
  - theme/b&b::15-neuro::07-other::08-parkinson‚äôs,-huntington‚äôs,-&-movement-disorders
  - source/ak-step1-v11::
  - theme/firstaid::12-neuro-&-special-senses::06-pharm::08-parkinson-disease-therapy
  - source/ak-step1-v11::
  - theme/firstaid::12-neuro-&-special-senses::06-pharm::08-parkinson-disease-therapy::carbidopa-levodopa
  - source/ak-step1-v11::
  - theme/firstaid::12-neuro-&-special-senses::06-pharm::09-carbidopa-levodopa
  - source/ak-step1-v11::
  - source/ome-banner::basic-science::01-dna-to-protein::17-amino-acids
  - source/ak-step1-v11::
  - theme/physeo::09-pharm::14-neuro::11-carbidopa/levodopa,-comt-inhibitors-(entacapone,-tolcapone)
  - source/ak-step1-v11::
  - theme/pixorize::02-biochem::02-pathways::11-catecholamine-synthesis-&-breakdown
  - source/ak-step1-v11::
  - theme/pixorize::03-pharm::15-other-neuro::levodopa,-carbidopa
  - source/ak-step1-v11::
  - theme/sketchybiochem::01-metabolism::02-amino-acids-&-proteins::03-catecholamine-synthesis-degradation
  - source/ak-step1-v11::
  - theme/sketchypharm::06-neuro/psych::05-antipsychotics-&-parkinsons::03-levodopa/carbidopa,-entacapone,-tolcapone,-selegiline,-ropinirole,-pramipexole,-amantadine
  - source/ak-step1-v11::^other::^highyield::1-highyield
  - source/ak-step1-v11::^systems::neuro::pharmacology
  - source/ak-step2-v11::
  - theme/b&b::04-neuro::03-movement-disorders::01-parkinson's-disease"
type: flashcard
---

# Question
Once in the CNS, L-DOPA may be converted to **dopamine** via the enzyme **DOPA decarboxylase**

---

# Answer
